Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Seres Therapeutics (MCRB) Return on Assets: 2016-2025

Historic Return on Assets for Seres Therapeutics (MCRB) over the last 10 years, with Sep 2025 value amounting to -0.70%.

  • Seres Therapeutics' Return on Assets fell 118.00% to -0.70% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.70%, marking a year-over-year decrease of 118.00%. This contributed to the annual value of 0.51% for FY2024, which is 29.00% up from last year.
  • Seres Therapeutics' Return on Assets amounted to -0.70% in Q3 2025, which was down 279.47% from 0.39% recorded in Q2 2025.
  • Seres Therapeutics' 5-year Return on Assets high stood at 0.61% for Q4 2024, and its period low was -0.79% during Q3 2022.
  • Its 3-year average for Return on Assets is 0.02%, with a median of -0.08% in 2024.
  • Its Return on Assets has fluctuated over the past 5 years, first surged by 72bps in 2024, then tumbled by 118bps in 2025.
  • Quarterly analysis of 5 years shows Seres Therapeutics' Return on Assets stood at -0.17% in 2021, then crashed by 38bps to -0.55% in 2022, then surged by 45bps to -0.10% in 2023, then soared by 71bps to 0.61% in 2024, then slumped by 118bps to -0.70% in 2025.
  • Its last three reported values are -0.70% in Q3 2025, 0.39% for Q2 2025, and 0.51% during Q1 2025.